 | • レポートコード：MRC2-11QY11554 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はサイトメガロウイルス（CMV）感染症のグローバル市場について調査・分析したレポートです。種類別（シドフォビル、ホスカルネット、バルガンシクロビル、ガンシクロビル）市場規模、用途別（病院、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別サイトメガロウイルス（CMV）感染症の競争状況、市場シェア ・世界のサイトメガロウイルス（CMV）感染症市場：種類別市場規模 2015年-2020年（シドフォビル、ホスカルネット、バルガンシクロビル、ガンシクロビル） ・世界のサイトメガロウイルス（CMV）感染症市場：種類別市場規模予測 2021年-2026年（シドフォビル、ホスカルネット、バルガンシクロビル、ガンシクロビル） ・世界のサイトメガロウイルス（CMV）感染症市場：用途別市場規模 2015年-2020年（病院、小売薬局、オンライン薬局） ・世界のサイトメガロウイルス（CMV）感染症市場：用途別市場規模予測 2021年-2026年（病院、小売薬局、オンライン薬局） ・北米のサイトメガロウイルス（CMV）感染症市場分析：米国、カナダ ・ヨーロッパのサイトメガロウイルス（CMV）感染症市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのサイトメガロウイルス（CMV）感染症市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のサイトメガロウイルス（CMV）感染症市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのサイトメガロウイルス（CMV）感染症市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、GlaxoSmithKline、Vical、AiCuris Anti-Infective Cures、ViroPharma、Chimerix ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Cytomegalovirus (CMV) infection is one of the common herpesvirus infection with different symptoms, which occurs in people of all ages across the globe. This viral infection is communicable and can easily spread through body fluids such as blood, urine, saliva, semen and breast milk. The infection can spread easily through saliva or urine and the people infected with the CMV may have the virus in their saliva or urine for months. The disease can be transmitted from pregnant women to the baby during the delivery. Blood transfusion and infected organ transplant is yet another mode of disease transmission.
The key factor responsible for growth of cytomegalovirus infection is increasing public awareness related to herpes virus infections which is fueling the diagnosis rate in North America and Europe. North America was observed as the largest market for cytomegalovirus infection treatment followed by Europe. Asia Pacific was anticipated to grow at a fastest CAGR during the forecast period. The key factors assisting the growth of Asia Pacific cytomegalovirus infection treatment market are the rising awareness associated with the rare diseases, developing healthcare infrastructure, high disposable income and government support for novel treatment against rare genetic diseases.
Market Analysis and Insights: Global Cytomegalovirus Infection Market
The global Cytomegalovirus Infection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cytomegalovirus Infection Scope and Market Size
Cytomegalovirus Infection market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cytomegalovirus Infection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche
GlaxoSmithKline
Vical
AiCuris Anti-Infective Cures
ViroPharma
Chimerix
…
Market segment by Type, the product can be split into
Cidofovir
Foscarnet
Valganciclovir
Ganciclovir
Market segment by Application, split into
Hospitals
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cytomegalovirus Infection Revenue
1.4 Market by Type
1.4.1 Global Cytomegalovirus Infection Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cidofovir
1.4.3 Foscarnet
1.4.4 Valganciclovir
1.4.5 Ganciclovir
1.5 Market by Application
1.5.1 Global Cytomegalovirus Infection Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cytomegalovirus Infection Market Perspective (2015-2026)
2.2 Global Cytomegalovirus Infection Growth Trends by Regions
2.2.1 Cytomegalovirus Infection Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cytomegalovirus Infection Historic Market Share by Regions (2015-2020)
2.2.3 Cytomegalovirus Infection Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cytomegalovirus Infection Market Growth Strategy
2.3.6 Primary Interviews with Key Cytomegalovirus Infection Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cytomegalovirus Infection Players by Market Size
3.1.1 Global Top Cytomegalovirus Infection Players by Revenue (2015-2020)
3.1.2 Global Cytomegalovirus Infection Revenue Market Share by Players (2015-2020)
3.1.3 Global Cytomegalovirus Infection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cytomegalovirus Infection Market Concentration Ratio
3.2.1 Global Cytomegalovirus Infection Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cytomegalovirus Infection Revenue in 2019
3.3 Cytomegalovirus Infection Key Players Head office and Area Served
3.4 Key Players Cytomegalovirus Infection Product Solution and Service
3.5 Date of Enter into Cytomegalovirus Infection Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cytomegalovirus Infection Historic Market Size by Type (2015-2020)
4.2 Global Cytomegalovirus Infection Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cytomegalovirus Infection Market Size by Application (2015-2020)
5.2 Global Cytomegalovirus Infection Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cytomegalovirus Infection Market Size (2015-2020)
6.2 Cytomegalovirus Infection Key Players in North America (2019-2020)
6.3 North America Cytomegalovirus Infection Market Size by Type (2015-2020)
6.4 North America Cytomegalovirus Infection Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cytomegalovirus Infection Market Size (2015-2020)
7.2 Cytomegalovirus Infection Key Players in Europe (2019-2020)
7.3 Europe Cytomegalovirus Infection Market Size by Type (2015-2020)
7.4 Europe Cytomegalovirus Infection Market Size by Application (2015-2020)
8 China
8.1 China Cytomegalovirus Infection Market Size (2015-2020)
8.2 Cytomegalovirus Infection Key Players in China (2019-2020)
8.3 China Cytomegalovirus Infection Market Size by Type (2015-2020)
8.4 China Cytomegalovirus Infection Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cytomegalovirus Infection Market Size (2015-2020)
9.2 Cytomegalovirus Infection Key Players in Japan (2019-2020)
9.3 Japan Cytomegalovirus Infection Market Size by Type (2015-2020)
9.4 Japan Cytomegalovirus Infection Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cytomegalovirus Infection Market Size (2015-2020)
10.2 Cytomegalovirus Infection Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cytomegalovirus Infection Market Size by Type (2015-2020)
10.4 Southeast Asia Cytomegalovirus Infection Market Size by Application (2015-2020)
11 India
11.1 India Cytomegalovirus Infection Market Size (2015-2020)
11.2 Cytomegalovirus Infection Key Players in India (2019-2020)
11.3 India Cytomegalovirus Infection Market Size by Type (2015-2020)
11.4 India Cytomegalovirus Infection Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cytomegalovirus Infection Market Size (2015-2020)
12.2 Cytomegalovirus Infection Key Players in Central & South America (2019-2020)
12.3 Central & South America Cytomegalovirus Infection Market Size by Type (2015-2020)
12.4 Central & South America Cytomegalovirus Infection Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview
13.1.3 Roche Cytomegalovirus Infection Introduction
13.1.4 Roche Revenue in Cytomegalovirus Infection Business (2015-2020))
13.1.5 Roche Recent Development
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Details
13.2.2 GlaxoSmithKline Business Overview
13.2.3 GlaxoSmithKline Cytomegalovirus Infection Introduction
13.2.4 GlaxoSmithKline Revenue in Cytomegalovirus Infection Business (2015-2020)
13.2.5 GlaxoSmithKline Recent Development
13.3 Vical
13.3.1 Vical Company Details
13.3.2 Vical Business Overview
13.3.3 Vical Cytomegalovirus Infection Introduction
13.3.4 Vical Revenue in Cytomegalovirus Infection Business (2015-2020)
13.3.5 Vical Recent Development
13.4 AiCuris Anti-Infective Cures
13.4.1 AiCuris Anti-Infective Cures Company Details
13.4.2 AiCuris Anti-Infective Cures Business Overview
13.4.3 AiCuris Anti-Infective Cures Cytomegalovirus Infection Introduction
13.4.4 AiCuris Anti-Infective Cures Revenue in Cytomegalovirus Infection Business (2015-2020)
13.4.5 AiCuris Anti-Infective Cures Recent Development
13.5 ViroPharma
13.5.1 ViroPharma Company Details
13.5.2 ViroPharma Business Overview
13.5.3 ViroPharma Cytomegalovirus Infection Introduction
13.5.4 ViroPharma Revenue in Cytomegalovirus Infection Business (2015-2020)
13.5.5 ViroPharma Recent Development
13.6 Chimerix
13.6.1 Chimerix Company Details
13.6.2 Chimerix Business Overview
13.6.3 Chimerix Cytomegalovirus Infection Introduction
13.6.4 Chimerix Revenue in Cytomegalovirus Infection Business (2015-2020)
13.6.5 Chimerix Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Cytomegalovirus Infection Key Market Segments
Table 2. Key Players Covered: Ranking by Cytomegalovirus Infection Revenue
Table 3. Ranking of Global Top Cytomegalovirus Infection Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cytomegalovirus Infection Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cidofovir
Table 6. Key Players of Foscarnet
Table 7. Key Players of Valganciclovir
Table 8. Key Players of Ganciclovir
Table 9. Global Cytomegalovirus Infection Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Cytomegalovirus Infection Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Cytomegalovirus Infection Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Cytomegalovirus Infection Market Share by Regions (2015-2020)
Table 13. Global Cytomegalovirus Infection Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Cytomegalovirus Infection Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Cytomegalovirus Infection Market Growth Strategy
Table 19. Main Points Interviewed from Key Cytomegalovirus Infection Players
Table 20. Global Cytomegalovirus Infection Revenue by Players (2015-2020) (Million US$)
Table 21. Global Cytomegalovirus Infection Market Share by Players (2015-2020)
Table 22. Global Top Cytomegalovirus Infection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cytomegalovirus Infection as of 2019)
Table 23. Global Cytomegalovirus Infection by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Cytomegalovirus Infection Product Solution and Service
Table 26. Date of Enter into Cytomegalovirus Infection Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cytomegalovirus Infection Market Size by Type (2015-2020) (Million US$)
Table 29. Global Cytomegalovirus Infection Market Size Share by Type (2015-2020)
Table 30. Global Cytomegalovirus Infection Revenue Market Share by Type (2021-2026)
Table 31. Global Cytomegalovirus Infection Market Size Share by Application (2015-2020)
Table 32. Global Cytomegalovirus Infection Market Size by Application (2015-2020) (Million US$)
Table 33. Global Cytomegalovirus Infection Market Size Share by Application (2021-2026)
Table 34. North America Key Players Cytomegalovirus Infection Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Cytomegalovirus Infection Market Share (2019-2020)
Table 36. North America Cytomegalovirus Infection Market Size by Type (2015-2020) (Million US$)
Table 37. North America Cytomegalovirus Infection Market Share by Type (2015-2020)
Table 38. North America Cytomegalovirus Infection Market Size by Application (2015-2020) (Million US$)
Table 39. North America Cytomegalovirus Infection Market Share by Application (2015-2020)
Table 40. Europe Key Players Cytomegalovirus Infection Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Cytomegalovirus Infection Market Share (2019-2020)
Table 42. Europe Cytomegalovirus Infection Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Cytomegalovirus Infection Market Share by Type (2015-2020)
Table 44. Europe Cytomegalovirus Infection Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Cytomegalovirus Infection Market Share by Application (2015-2020)
Table 46. China Key Players Cytomegalovirus Infection Revenue (2019-2020) (Million US$)
Table 47. China Key Players Cytomegalovirus Infection Market Share (2019-2020)
Table 48. China Cytomegalovirus Infection Market Size by Type (2015-2020) (Million US$)
Table 49. China Cytomegalovirus Infection Market Share by Type (2015-2020)
Table 50. China Cytomegalovirus Infection Market Size by Application (2015-2020) (Million US$)
Table 51. China Cytomegalovirus Infection Market Share by Application (2015-2020)
Table 52. Japan Key Players Cytomegalovirus Infection Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Cytomegalovirus Infection Market Share (2019-2020)
Table 54. Japan Cytomegalovirus Infection Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Cytomegalovirus Infection Market Share by Type (2015-2020)
Table 56. Japan Cytomegalovirus Infection Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Cytomegalovirus Infection Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Cytomegalovirus Infection Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Cytomegalovirus Infection Market Share (2019-2020)
Table 60. Southeast Asia Cytomegalovirus Infection Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Cytomegalovirus Infection Market Share by Type (2015-2020)
Table 62. Southeast Asia Cytomegalovirus Infection Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Cytomegalovirus Infection Market Share by Application (2015-2020)
Table 64. India Key Players Cytomegalovirus Infection Revenue (2019-2020) (Million US$)
Table 65. India Key Players Cytomegalovirus Infection Market Share (2019-2020)
Table 66. India Cytomegalovirus Infection Market Size by Type (2015-2020) (Million US$)
Table 67. India Cytomegalovirus Infection Market Share by Type (2015-2020)
Table 68. India Cytomegalovirus Infection Market Size by Application (2015-2020) (Million US$)
Table 69. India Cytomegalovirus Infection Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Cytomegalovirus Infection Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Cytomegalovirus Infection Market Share (2019-2020)
Table 72. Central & South America Cytomegalovirus Infection Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Cytomegalovirus Infection Market Share by Type (2015-2020)
Table 74. Central & South America Cytomegalovirus Infection Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Cytomegalovirus Infection Market Share by Application (2015-2020)
Table 76. Roche Company Details
Table 77. Roche Business Overview
Table 78. Roche Product
Table 79. Roche Revenue in Cytomegalovirus Infection Business (2015-2020) (Million US$)
Table 80. Roche Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Product
Table 84. GlaxoSmithKline Revenue in Cytomegalovirus Infection Business (2015-2020) (Million US$)
Table 85. GlaxoSmithKline Recent Development
Table 86. Vical Company Details
Table 87. Vical Business Overview
Table 88. Vical Product
Table 89. Vical Revenue in Cytomegalovirus Infection Business (2015-2020) (Million US$)
Table 90. Vical Recent Development
Table 91. AiCuris Anti-Infective Cures Company Details
Table 92. AiCuris Anti-Infective Cures Business Overview
Table 93. AiCuris Anti-Infective Cures Product
Table 94. AiCuris Anti-Infective Cures Revenue in Cytomegalovirus Infection Business (2015-2020) (Million US$)
Table 95. AiCuris Anti-Infective Cures Recent Development
Table 96. ViroPharma Company Details
Table 97. ViroPharma Business Overview
Table 98. ViroPharma Product
Table 99. ViroPharma Revenue in Cytomegalovirus Infection Business (2015-2020) (Million US$)
Table 100. ViroPharma Recent Development
Table 101. Chimerix Company Details
Table 102. Chimerix Business Overview
Table 103. Chimerix Product
Table 104. Chimerix Revenue in Cytomegalovirus Infection Business (2015-2020) (Million US$)
Table 105. Chimerix Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cytomegalovirus Infection Market Share by Type: 2020 VS 2026
Figure 2. Cidofovir Features
Figure 3. Foscarnet Features
Figure 4. Valganciclovir Features
Figure 5. Ganciclovir Features
Figure 6. Global Cytomegalovirus Infection Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Cytomegalovirus Infection Report Years Considered
Figure 11. Global Cytomegalovirus Infection Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cytomegalovirus Infection Market Share by Regions: 2020 VS 2026
Figure 13. Global Cytomegalovirus Infection Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cytomegalovirus Infection Market Share by Players in 2019
Figure 16. Global Top Cytomegalovirus Infection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cytomegalovirus Infection as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cytomegalovirus Infection Revenue in 2019
Figure 18. North America Cytomegalovirus Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cytomegalovirus Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cytomegalovirus Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cytomegalovirus Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cytomegalovirus Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cytomegalovirus Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cytomegalovirus Infection Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
サイトメガロウイルス（HHV-5）感染症治療薬の世界市場（～2026年） A drug used to treat giant cell infections. Market Analysis and Insights: Global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs Market The global Cytomegalovirus（HHV-5）Infection Therapeutic Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of X…- サイトメガロウイルス（CMV）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Cytomegalovirus Therapeutics Market The global Cytomegalovirus Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cytomegalovirus Therapeutics Scope and Market Size Cytome…
- サイトメガロウイルス（CMV）網膜炎治療の世界市場（～2026年） Ophthalmology is the branch of medical science that deals with the management and study of anatomy, physiology, and diseases related to the human eye. Globally, the incidence of eye disorders and vision loss are becoming major public health issues. Some of the major eye diseases include age-related …
- 尿路感染症治療の世界市場（～2026年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…
- ペプチド感染症治療薬の世界市場（～2026年） Peptide therapeutics are stable, safe, tolerable, possess selective nature, and effective. Hospital pharmacies segment enjoys the highest market share by revenue thereby dominating the global market. Market Analysis and Insights: Global Peptide Based Infection Therapeutics Market The global Peptide …